Weight of salivary gland ultrasonography compared to other items of the 2016 ACR/EULAR classification criteria for Primary Sjögren's syndrome.

Primary Sjögren’s syndrome classification criteria diagnosis salivary glands ultrasonography

Journal

Journal of internal medicine
ISSN: 1365-2796
Titre abrégé: J Intern Med
Pays: England
ID NLM: 8904841

Informations de publication

Date de publication:
02 2020
Historique:
pubmed: 17 10 2019
medline: 29 9 2020
entrez: 17 10 2019
Statut: ppublish

Résumé

Major salivary gland ultrasonography (SGUS) is widely used for the diagnosis of primary Sjögren's syndrome (pSS). Our objective was to assess the contribution of SGUS compared to other items of the 2016 ACR/EULAR pSS classification criteria, based on expert opinion. A secure web-based relational database was used by 24 experts from 14 countries to assess 512 realistic vignettes developed from data of patients with suspected pSS. Each vignette provided classification criteria items and information on history, clinical symptoms and SGUS findings. Each expert assessed 64 vignettes, and each vignette was assessed by 3 experts. A diagnosis of pSS was defined according to at least 2 of 3 experts. Validation was performed in the independent French DiapSS cohort of patients with suspected pSS. A criteria-based pSS diagnosis and SGUS findings were independently associated with an expert diagnosis of pSS (P < 0.001). The derived diagnostic weights of individual items in the 2016 ACR/EULAR criteria including SGUS were as follows: anti-SSA, 3; focus score ≥ 1, 3; SGUS score ≥ 2, 1; positive Schirmer's test, 1; dry mouth, 1; and salivary flow rate < 0.1 mL/min, 1. The corrected C statistic area under the curve for the new weighted score was 0.96. Adding SGUS improves the sensitivity from 90.2 % to 95.6% with a quite similar specificity 84.1% versus 82.6%. Results were similar in the DiapSS cohort: adding SGUS improves the sensitivity from 87% to 93%. SGUS had similar weight compared to minor items, and its addition improves the performance of the 2016 ACR/EULAR classification criteria.

Identifiants

pubmed: 31618794
doi: 10.1111/joim.12992
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

180-188

Subventions

Organisme : Versus Arthritis
ID : 21236
Pays : United Kingdom

Informations de copyright

© 2019 The Association for the Publication of the Journal of Internal Medicine.

Références

Mariette X, Criswell LA. Primary Sjogren's Syndrome. N Engl J Med 2018; 379(1): 97.
Saraux A, Pers JO, Devauchelle-Pensec V. Treatment of primary Sjogren syndrome. Nat Rev Rheumatol 2016; 12(8): 456-71.
Fisher BA, Jonsson R, Daniels T et al. Standardisation of labial salivary gland histopathology in clinical trials in primary Sjogren's syndrome. Ann Rheum Dis 2017; 76(7): 1161-8.
Guellec D, Cornec D, Jousse-Joulin S et al. Diagnostic value of labial minor salivary gland biopsy for Sjogren's syndrome: a systematic review. Autoimmun Rev 2013; 12(3): 416-20.
Vitali C, Monti P, Giuggioli C et al. Parotid sialography and lip biopsy in the evaluation of oral component in Sjogren's syndrome. Clin Exp Rheumatol 1989; 7(2): 131-5.
Devauchelle-Pensec V, Zabotti A, Carvajal-Alegria G, Filipovic N, Jousse-Joulin S, De Vita S. Salivary gland ultrasonography in primary Sjogren's syndrome: opportunities and challenges. Rheumatology (Oxford) 2019; pii: kez079. https://doi.org/10.1093/rheumatology/kez079.
Carotti M, Salaffi F, Manganelli P, Argalia G. Ultrasonography and colour doppler sonography of salivary glands in primary Sjogren's syndrome. Clin Rheumatol 2001; 20(3): 213-9.
De Vita S, Lorenzon G, Rossi G, Sabella M, Fossaluzza V. Salivary gland echography in primary and secondary Sjogren's syndrome. Clin Exp Rheumatol 1992; 10(4): 351-6.
Yonetsu K, Takagi Y, Sumi M, Nakamura T, Eguchi K. Sonography as a replacement for sialography for the diagnosis of salivary glands affected by Sjogren's syndrome. Ann Rheum Dis 2002; 61(3): 276-7.
Cornec D, Jousse-Joulin S, Marhadour T et al. Salivary gland ultrasonography improves the diagnostic performance of the 2012 American College of Rheumatology classification criteria for Sjogren's syndrome. Rheumatology (Oxford) 2014; 53(9): 1604-7.
Hammenfors DS, Brun JG, Jonsson R, Jonsson MV. Diagnostic utility of major salivary gland ultrasonography in primary Sjogren's syndrome. Clin Exp Rheumatol 2015; 33(1): 56-62.
Milic VD, Petrovic RR, Boricic IV et al. Diagnostic value of salivary gland ultrasonographic scoring system in primary Sjogren's syndrome: a comparison with scintigraphy and biopsy. J Rheumatol 2009; 36(7): 1495-500.
Mossel E, Delli K, van Nimwegen JF et al. Ultrasonography of major salivary glands compared with parotid and labial gland biopsy and classification criteria in patients with clinically suspected primary Sjogren's syndrome. Ann Rheum Dis 2017; 76(11): 1883-9. https://doi.org/10.1136/annrheumdis-2017-211250.
Wernicke D, Hess H, Gromnica-Ihle E, Krause A, Schmidt WA. Ultrasonography of salivary glands - a highly specific imaging procedure for diagnosis of Sjogren's syndrome. J Rheumatol 2008; 35(2): 285-93.
Shiboski CH, Shiboski SC, Seror R et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjogren's syndrome: A consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis 2017; 76(1): 9-16.
Shiboski CH, Shiboski SC, Seror R et al. 2016 American college of rheumatology/European League against rheumatism classification criteria for primary Sjogren's Syndrome: A consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 2017; 69(1): 35-45.
Seror R, Ravaud P, Bowman SJ et al. EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. Ann Rheum Dis 2010; 69(6): 1103-9.
Cornec D, Jousse-Joulin S, Pers JO et al. Contribution of salivary gland ultrasonography to the diagnosis of Sjogren's syndrome: toward new diagnostic criteria? Arthritis Rheum 2013; 65(1): 216-25.
Le Goff M, Cornec D, Jousse-Joulin S et al. Comparison of 2002 AECG and 2016 ACR/EULAR classification criteria and added value of salivary gland ultrasonography in a patient cohort with suspected primary Sjogren's syndrome. Arthritis Res Ther 2017; 19(1): 269.
Jousse-Joulin S, Milic V, Jonsson MV et al. Is salivary gland ultrasonography a useful tool in Sjogren's syndrome? A systematic review. Rheumatology (Oxford) 2016; 55(5): 789-800.
Jousse-Joulin S, Nowak E, Cornec D et al. Salivary gland ultrasound abnormalities in primary Sjogren's syndrome: consensual US-SG core items definition and reliability. RMD Open 2017; 3(1): e000364.
Mossel E, Delli K, van Nimwegen JF et al. The parotid gland connection: ultrasound and biopsies in primary Sjogren's syndrome. Ann Rheum Dis 2017; 77(7): e38.
Baldini C, Pepe P, Quartuccio L et al. Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients. Rheumatology (Oxford) 2014; 53(5): 839-44.
Vitali C, Palombi G, Baldini C et al. Sjogren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjogren's syndrome, derived from an analysis of a cohort of Italian patients. Arthritis Rheum 2007; 56(7): 2223-31.
Gazeau P, Cornec D, Jousse-Joulin S, Guellec D, Saraux A, Devauchelle-Pensec V. Time-course of ultrasound abnormalities of major salivary glands in suspected Sjogren's syndrome. Joint Bone Spine 2018; 85(2): 227-32.
Jonsson MV, Baldini C. Major salivary gland ultrasonography in the diagnosis of Sjogren's Syndrome: A place in the diagnostic criteria? Rheum Dis Clin North Am 2016; 42(3): 501-17.
Bootsma H, Spijkervet FK, Kroese FG, Vissink A. Toward new classification criteria for Sjogren's syndrome? Arthritis Rheum 2013; 65(1): 21-3.
Vitali C, Carotti M, Salaffi F. Is it the time to adopt salivary gland ultrasonography as an alternative diagnostic tool for the classification of patients with Sjogren's syndrome? Arthritis Rheum 2013; 65(7): 1950.
Cornec D, Saraux A, Pers JO et al. Diagnostic accuracy of blood B-cell subset profiling and autoimmunity markers in Sjogren's syndrome. Arthritis Res Ther 2014; 16(1): R15.
Christodoulou MI, Kapsogeorgou EK, Moutsopoulos HM. Characteristics of the minor salivary gland infiltrates in Sjogren's syndrome. J Autoimmun 2010; 34(4): 400-7.
Jousse-Joulin S, D'Agostino MA, Nicolas C et al. Video clip assessment of a salivary gland ultrasound scoring system in Sjogren's syndrome using consensual definitions: an OMERACT ultrasound working group reliability exercise. Ann Rheum Dis 2019; 78(7): 967-73.

Auteurs

S Jousse-Joulin (S)

From the, Rheumatology Department, INSERM UMR 1227, Cavale Blanche Hospital and Brest Occidentale University, Brest, France.

F Gatineau (F)

INSERM CIC 1412, Brest Medical University Hospital, Brest, France.

C Baldini (C)

Rheumatology Unit, University of Pisa, Pisa, Italy.

A Baer (A)

Department of Medicine (Rheumatology), Johns Hopkins University School of Medicine, Baltimore, MD, USA.

F Barone (F)

Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.

H Bootsma (H)

Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.

S Bowman (S)

Department of Rheumatology, University Hospitals, Birmingham NHS Trust, Birmingham, UK.

P Brito-Zerón (P)

Autoimmune Diseases Unit, Department of Medicine, Hospital CIMA- Sanitas, Barcelona, Spain.

D Cornec (D)

From the, Rheumatology Department, INSERM UMR 1227, Cavale Blanche Hospital and Brest Occidentale University, Brest, France.

T Dorner (T)

Department of Medicine, Rheumatology and Clinical Immunology, Charite Universitätsmedizin Berlin and DRFZ Berlin, Berlin, Germany.

S de Vita (S)

Clinic of Rheumatology, Department of Medical and Biological Sciences, University Hospital "Santa Maria della Misericordia", Udine, Italy.

B Fisher (B)

Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.

D Hammenfors (D)

Department of Rheumatology, Haukeland University Hospital, Bergen, Norway.
Section for Rheumatology, Department of Clinical Science, University of Bergen, Bergen, Norway.

M Jonsson (M)

Section for Oral and Maxillofacial Radiology, Department of Clinical Dentistry, University of Bergen, Bergen, Norway.

X Mariette (X)

Center for Immunology of Viral Infections and Autoimmune Diseases, Assistance Publique, Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, France.
INSERM, Université Paris Sud, Paris, France.

V Milic (V)

Institute of Rheumatology, School of Medicine, University of Belgrade, Belgrade, Serbia.

H Nakamura (H)

Department of Immunology and Rheumatology, Unit of Advanced Medical Sciences, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

W-F Ng (WF)

Institute of Cellular Medicine, Newcastle University & NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne, UK.

E Nowak (E)

INSERM CIC 1412, Brest Medical University Hospital, Brest, France.

M Ramos-Casals (M)

Autoimmune Diseases Unit, Department of Medicine, Hospital CIMA- Sanitas, Barcelona, Spain.

A Rasmussen (A)

Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.

R Seror (R)

Center for Immunology of Viral Infections and Autoimmune Diseases, Assistance Publique, Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, France.
INSERM, Université Paris Sud, Paris, France.

C H Shiboski (CH)

Department of Orofacial Sciences, School of Dentistry, University of California, San Francisco, CA, USA.

T Nakamura (T)

Department of Radiology and Cancer Biology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

A Vissink (A)

Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.

A Saraux (A)

From the, Rheumatology Department, INSERM UMR 1227, Cavale Blanche Hospital and Brest Occidentale University, Brest, France.

V Devauchelle-Pensec (V)

From the, Rheumatology Department, INSERM UMR 1227, Cavale Blanche Hospital and Brest Occidentale University, Brest, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH